For example, ephrin-A5 expressed by RAs in the peri-infarction region can inhibit axon regeneration, and inhibition of ephrin-A5 in the peri-infarction area can promote axon growth on day seven after stroke (Overman et al., 2012), which provides a long treatment time window so that has broad clinical prospects. Here, EFNA5 is linked to stroke disorder.